Daiichi Sankyo France clinical trials

A country office of Daiichi Sankyo

The registry lists 1 studies whose lead sponsor is Daiichi Sankyo France. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 26, 2024.

Status

Completed: 1

Where

France: 1

Registry sponsor names on this page

Daiichi Sankyo France1 study

Something wrong with this grouping? Tell us on the Daiichi Sankyo page.

Studies

Recruiting first, then most recently updated. Showing 1 of 1. All Daiichi Sankyo studies →

Safety, Effectiveness and Quality of Life of Trastuzumab Deruxtecan in Patients with HER2+ Breast CancerCompletedNCT05149014
Sponsor listed in the registry: Daiichi Sankyo France